Point72 Asset Management
EVH icon

Point72 Asset Management’s Evolent Health EVH Stock Holding History

Point72 Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-564,954
Closed -$2.26M – 3986
2025
Q4 		$2.26M Sell
564,954
-37,025
-6% -$206K ﹤0.01% 2400
2025
Q3 		$5.09M Buy
+601,979
New +$5.84M 0.01% 1058
2025
Q2 		– Sell
-1,487,896
Closed -$14.1M – 2318
2025
Q1 		$14.1M Buy
1,487,896
+1,206,752
+429% +$12.2M 0.03% 553
2024
Q4 		$3.16M Sell
281,144
-1,214,241
-81% -$21.3M 0.01% 1087
2024
Q3 		$42.3M Buy
1,495,385
+1,422,385
+1,948% +$36.7M 0.11% 221
2024
Q2 		$1.4M Sell
73,000
-1,870,385
-96% -$47.8M ﹤0.01% 1189
2024
Q1 		$63.7M Sell
1,943,385
-731,615
-27% -$23.3M 0.15% 141
2023
Q4 		$88.4M Buy
2,675,000
+1,199,400
+81% +$33.9M 0.21% 109
2023
Q3 		$40.2M Buy
+1,475,600
New +$41M 0.12% 220
2023
Q2 		– Sell
-308,184
Closed -$10M – 2350
2023
Q1 		$10M Sell
308,184
-2,962,492
-91% -$93.7M 0.03% 547
2022
Q4 		$91.8M Buy
3,270,676
+1,487,856
+83% +$42.7M 0.31% 69
2022
Q3 		$64.1M Buy
1,782,820
+1,104,118
+163% +$38.9M 0.26% 100
2022
Q2 		$20.8M Sell
678,702
-737,735
-52% -$21.5M 0.09% 303
2022
Q1 		$45.8M Buy
1,416,437
+989,701
+232% +$25.9M 0.18% 158
2021
Q4 		$11.8M Buy
426,736
+5,080
+1% +$146K 0.05% 468
2021
Q3 		$13.1M Buy
+421,656
New +$10.1M 0.06% 426
2021
Q2 		– Sell
-534,889
Closed -$10.8M – 1027
2021
Q1 		$10.8M Sell
534,889
-237,738
-31% -$4.52M 0.05% 410
2020
Q4 		$12.4M Buy
772,627
+143,747
+23% +$1.9M 0.06% 391
2020
Q3 		$7.8M Buy
628,880
+95,335
+18% +$1.12M 0.04% 463
2020
Q2 		$3.8M Buy
+533,545
New +$3.57M 0.02% 518
2020
Q1 		– Sell
-1,200,729
Closed -$10.9M – 870
2019
Q4 		$10.9M Buy
1,200,729
+677,205
+129% +$5.5M 0.06% 365
2019
Q3 		$3.76M Buy
+523,524
New +$3.76M 0.02% 503
2019
Q2 		– Sell
-109,259
Closed -$1.37M – 1391
2019
Q1 		$1.37M Sell
109,259
-66,575
-38% -$1.05M 0.01% 764
2018
Q4 		$3.51M Buy
+175,834
New +$4.07M 0.02% 624
2018
Q2 		– Sell
-370,000
Closed -$5.27M – 1028
2018
Q1 		$5.27M Sell
370,000
-301,300
-45% -$4.31M 0.02% 569
2017
Q4 		$8.26M Buy
671,300
+274,300
+69% +$3.87M 0.04% 487
2017
Q3 		$7.07M Sell
397,000
-82,626
-17% -$1.7M 0.03% 477
2017
Q2 		$12.2M Buy
+479,626
New +$11.5M 0.07% 348

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's EVH Position: Q1 2026 in Review

Point72 Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 564,954 shares — an estimated $2.26M sold.

Point72 Asset Management first reported a position in EVH in Q2 2017 and held it in 28 quarters. The position peaked at $91.8M in Q4 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Point72 Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 564,954 Evolent Health shares in Q1 2026, an estimated $2.26M.
  • Point72 Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 28 quarters.
  • Point72 Asset Management's Evolent Health position peaked at $91.8M in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.